Suchergebnisse - "Dorman, Klara"

PubPharm (24)

1

Unresectable biliary tract cancer : Current and future systemic therapy

enthalten in: European journal of cancer (Oxford, England : 1990) | 2024

von Zhang, D. | Dorman, K. | Westphalen, C. | +11

2

Three-month life expectancy as inclusion criterion for clinical trials in advanced pancreatic cancer : is it really a valid tool for patient selection?

enthalten in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico | 2024

von Weiss, L. | Heinemann, V. | Fischer, L. | +17

3

Gemcitabine and nab-paclitaxel combined with afatinib in metastatic pancreatic cancer - Results of a phase 1b clinical trial

enthalten in: European journal of cancer (Oxford, England : 1990) | 2024

von Zhang, D. | Benedikt Westphalen, C. | Quante, M. | +11

4

A rare case of locally advanced DNA mismatch-repair-deficient adenocarcinoma of the colon in a 16-year-old male treated with neoadjuvant immunotherapy and single-incision laparoscopic resection

enthalten in: Pediatric blood & cancer | 2023

von Zhang, D. | Muensterer, O. | Neumann, J. | +4

5

Three-month life expectancy as inclusion criterion for clinical trials in advanced pancreatic cancer: is it really a valid tool for patient selection?

enthalten in: Clinical and translational oncology | 2023

von Weiss, L. | Heinemann, V. | Fischer, L. | +17

6

A Retrospective Analysis of Biliary Tract Cancer Patients Presented to the Molecular Tumor Board at the Comprehensive Cancer Center Munich

enthalten in: Targeted oncology | 2023

von Zhang, D. | Dorman, K. | Heinrich, K. | +26

7

Zielgerichtete Therapie des Pankreaskarzinoms

enthalten in: Die Onkologie | 2023

von Witte, D. | Dorman, K. | Zhang, D. | +1

8

Zielgerichtete Therapie des Pankreaskarzinoms

enthalten in: Die Onkologie | 2023

von Witte, D. | Dorman, K. | Zhang, D. | +1

9

Serum biomarker panel diagnostics in pancreatic ductal adenocarcinoma : the clinical utility of soluble interleukins, IFN-γ, TNF-α and PD-1/PD-L1 in comparison to established serum tumor markers

enthalten in: Journal of cancer research and clinical oncology | 2023

von Dorman, K. | Gerckens, M. | Kruger, S. | +15

10

Integrated Analysis of the RASH Study with the Use of the "Burden of Therapy" (BOTh®TM) Methodology-A Novel Tool for Assessing Adverse Events in Metastatic Pancreatic Cancer

enthalten in: Current oncology (Toronto, Ont.) | 2023

von Dorman, K. | Boeck, S. | Snijder, R. | +18